Toward the harmonization of immune monitoring in clinical trials: Quo vadis?

被引：48

作者：

Britten, C. M. ^{[1
]}

Janetzki, S. ^{[2
]}

van der Burg, S. H. ^{[3
]}

Gouttefangeas, C. ^{[4
]}

Hoos, A. ^{[5
]}

机构：

[1] Leiden Univ, Med Ctr, Dept Immunohaematol & Blood Transfus, Leiden, Netherlands

[2] ZellNet Consulting Inc, Ft Lee, NJ USA

[3] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands

[4] Univ Tubingen, Dept Immunol, D-72074 Tubingen, Germany

[5] Bristol Myers Squibb Co, Wallingford, CT USA

来源：

CANCER IMMUNOLOGY IMMUNOTHERAPY | 2008年 / 57卷 / 03期

关键词：

D O I：

10.1007/s00262-007-0379-z

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：285 / 288

页数：4

共 11 条

[1]

BRITTEN CM, 2007, CANC IMMUNOL IMMUNOT

[2] Definition of an immunologic response using the major histocompatibility complex tetramer and enzyme-linked immunospot assays [J].

Comin-Anduix, B ;

Gualberto, A ;

Glaspy, JA ;

Seja, E ;

Ontiveros, M ;

Reardon, DL ;

Renteria, R ;

Englahner, B ;

Economou, JS ;

Gomez-Navarro, J ;

Ribas, A .

CLINICAL CANCER RESEARCH, 2006, 12 (01) :107-116

[3] Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials [J].

Cox, JH ;

Ferrari, G ;

Kalams, SA ;

Lopaczynski, W ;

Oden, N ;

D'Souza, MP .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2005, 21 (01) :68-81

[4]

HANEKOM WA, 2007, UNPUB IMMUNOLOGICAL

[5] A clinical development paradigm for cancer vaccines and related biologics [J].

Hoos, Axel ;

Parmiani, Giorgio ;

Hege, Kristen ;

Sznol, Mario ;

Loibner, Hans ;

Eggermont, Alexander ;

Urba, Walter ;

Blumenstein, Brent ;

Sacks, Natalie ;

Keilholz, Ulrich ;

Nichol, Geoffrey .

JOURNAL OF IMMUNOTHERAPY, 2007, 30 (01) :1-15

[6]

Janetzki Sylvia, 2005, Methods Mol Biol, V302, P51

[7] Immunologic monitoring of cancer vaccine therapy: Results of a workshop sponsored by the Society for Biological Therapy [J].

Keilholz, U ;

Weber, J ;

Finke, JH ;

Gabrilovich, DI ;

Kast, WM ;

Disis, ML ;

Kirkwood, JM ;

Scheibenbogen, C ;

Schlom, J ;

Maino, VC ;

Lyerly, HK ;

Lee, PP ;

Storkus, W ;

Marincola, F ;

Worobec, A ;

Atkins, MB .

JOURNAL OF IMMUNOTHERAPY, 2002, 25 (02) :97-138

[8] Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination [J].

Romero, P ;

Cerottini, JC ;

Speiser, DE .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (03) :249-255

[9] Cancer immunotherapy: moving beyond current vaccines [J].

Rosenberg, SA ;

Yang, JC ;

Restifo, NP .

NATURE MEDICINE, 2004, 10 (09) :909-915

[10] Quantitation of antigen-reactive T cells in peripheral blood by IFNγ-ELISPOT assay and chromium-release assay:: a four-centre comparative trial [J].

Scheibenbogen, C ;

Romero, P ;

Rivoltini, L ;

Herr, W ;

Schmittel, A ;

Cerottini, JC ;

Woelfel, T ;

Eggermont, AMM ;

Keilholz, U .

JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 244 (1-2) :81-89

← 1 2 →